Haiyin Capital

Haiyin Capital is a Beijing-based venture capital firm that focuses on early-stage investments in technology, healthcare, cleantech, renewable energy, and financial services sectors across Asia-Pacific and the United States. The firm actively seeks technology teams whose innovations are poised for global impact.

The firm's investment strategy emphasizes leveraging its strong industrial background and resources in China to help portfolio companies achieve rapid growth. Haiyin Capital assists its investees in penetrating the Chinese market, connecting with China's supply chain, and facilitating further fundraising from Chinese investors.

Haiyin Capital has invested in several high-tech companies in the U.S., primarily university spin-offs. Notable investments include medical device companies such as Wicab, Cerevast, and MC10; robotics companies like Soft Robotics and Hanson Robotics; and energy companies such as WiTricity and 1366 Tech. Through its investments, Haiyin Capital aims to bridge the gap between Chinese investors and American university startups, fostering innovation and growth in both regions.